KalVista Pharmaceuticals (KALV) Current Leases (2017 - 2024)
Historic Current Leases for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q4 2024 value amounting to $1.5 million.
- KalVista Pharmaceuticals' Current Leases changed N/A to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2024, which is N/A changed from last year.
- KalVista Pharmaceuticals' Current Leases amounted to $1.5 million in Q4 2024.
- KalVista Pharmaceuticals' Current Leases' 5-year high stood at $1.5 million during Q4 2024, with a 5-year trough of $422000.0 in Q4 2020.
- For the 4-year period, KalVista Pharmaceuticals' Current Leases averaged around $976583.3, with its median value being $1.1 million (2023).
- Over the last 5 years, KalVista Pharmaceuticals' Current Leases had its largest YoY gain of 98888.89% in 2020, and its largest YoY loss of 2990.03% in 2020.
- KalVista Pharmaceuticals' Current Leases (Quarter) stood at $422000.0 in 2020, then soared by 40.28% to $592000.0 in 2021, then soared by 93.92% to $1.1 million in 2023, then rose by 26.48% to $1.5 million in 2024.
- Its Current Leases stands at $1.5 million for Q4 2024, versus $1.5 million for Q4 2024 and $1.3 million for Q3 2024.